152 related articles for article (PubMed ID: 37150708)
1. Corrigendum to "Immune response of C57BL/6J mice to herpes zoster subunit vaccines formulated with nanoemulsion-based and liposome-based adjuvants" [Int. Immunopharmacol. 101(Part B) (2021) 108216].
He L; Sun B; Guo Y; Yan K; Liu D; Zang Y; Jiang C; Zhang Y; Kong W
Int Immunopharmacol; 2023 Jun; 119():110260. PubMed ID: 37150708
[No Abstract] [Full Text] [Related]
2. Immune response of C57BL/6J mice to herpes zoster subunit vaccines formulated with nanoemulsion-based and liposome-based adjuvants.
He L; Sun B; Guo Y; Yan K; Liu D; Zang Y; Jiang C; Zhang Y; Kong W
Int Immunopharmacol; 2021 Dec; 101(Pt B):108216. PubMed ID: 34634689
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of glycoprotein E subunit and live attenuated varicella-zoster virus vaccines formulated with a single-strand RNA-based adjuvant.
Lee SJ; Park HJ; Ko HL; Lee JE; Lee HJ; Kim H; Nam JH
Immun Inflamm Dis; 2020 Jun; 8(2):216-227. PubMed ID: 32167678
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the Immune Effects of an mRNA Vaccine and a Subunit Vaccine against Herpes Zoster Administered by Different Injection Methods.
Lin K; Cao H; Luan N; Wang Y; Hu J; Liu C
Vaccines (Basel); 2023 May; 11(5):. PubMed ID: 37243107
[TBL] [Abstract][Full Text] [Related]
5. LNP-CpG ODN-adjuvanted varicella-zoster virus glycoprotein E induced comparable levels of immunity with Shingrix™ in VZV-primed mice.
Luan N; Cao H; Wang Y; Lin K; Liu C
Virol Sin; 2022 Oct; 37(5):731-739. PubMed ID: 35671982
[TBL] [Abstract][Full Text] [Related]
6. Comparative preclinical evaluation of AS01 versus other Adjuvant Systems in a candidate herpes zoster glycoprotein E subunit vaccine.
Fochesato M; Dendouga N; Boxus M
Hum Vaccin Immunother; 2016 Aug; 12(8):2092-2095. PubMed ID: 26933767
[TBL] [Abstract][Full Text] [Related]
7. Immunogenicity and Safety of the HZ/su Adjuvanted Herpes Zoster Subunit Vaccine in Adults Previously Vaccinated With a Live Attenuated Herpes Zoster Vaccine.
Grupping K; Campora L; Douha M; Heineman TC; Klein NP; Lal H; Peterson J; Vastiau I; Oostvogels L
J Infect Dis; 2017 Dec; 216(11):1343-1351. PubMed ID: 29029122
[TBL] [Abstract][Full Text] [Related]
8. Prophylactic Herpes Simplex Virus 2 (HSV-2) Vaccines Adjuvanted with Stable Emulsion and Toll-Like Receptor 9 Agonist Induce a Robust HSV-2-Specific Cell-Mediated Immune Response, Protect against Symptomatic Disease, and Reduce the Latent Viral Reservoir.
Hensel MT; Marshall JD; Dorwart MR; Heeke DS; Rao E; Tummala P; Yu L; Cohen GH; Eisenberg RJ; Sloan DD
J Virol; 2017 May; 91(9):. PubMed ID: 28228587
[TBL] [Abstract][Full Text] [Related]
9. Corrigendum to "Evaluation of different types of adjuvants in a malaria transmission-blocking vaccine" [Int. Immunopharmacol. 131 (2024) 111817].
Yu X; Min H; Yao S; Yao G; Zhang D; Zhang B; Chen M; Liu F; Cui L; Zheng L; Cao Y
Int Immunopharmacol; 2024 Jun; ():112260. PubMed ID: 38926073
[No Abstract] [Full Text] [Related]
10. Efficient induction of cell-mediated immunity to varicella-zoster virus glycoprotein E co-lyophilized with a cationic liposome-based adjuvant in mice.
Wui SR; Kim KS; Ryu JI; Ko A; Do HTT; Lee YJ; Kim HJ; Lim SJ; Park SA; Cho YJ; Kim CG; Lee NG
Vaccine; 2019 Apr; 37(15):2131-2141. PubMed ID: 30827737
[TBL] [Abstract][Full Text] [Related]
11. Immune Responses to Varicella-Zoster Virus Glycoprotein E Formulated with Poly(Lactic-co-Glycolic Acid) Nanoparticles and Nucleic Acid Adjuvants in Mice.
Wang Y; Qi J; Cao H; Liu C
Virol Sin; 2021 Feb; 36(1):122-132. PubMed ID: 32757147
[TBL] [Abstract][Full Text] [Related]
12. Comparative Antibody Responses to the Live-Attenuated and Recombinant Herpes Zoster Vaccines.
Schmid DS; Miao C; Leung J; Johnson M; Weinberg A; Levin MJ
J Virol; 2021 May; 95(12):. PubMed ID: 33762414
[TBL] [Abstract][Full Text] [Related]
13. Efficacy, effectiveness, and safety of herpes zoster vaccines in adults aged 50 and older: systematic review and network meta-analysis.
Tricco AC; Zarin W; Cardoso R; Veroniki AA; Khan PA; Nincic V; Ghassemi M; Warren R; Sharpe JP; Page AV; Straus SE
BMJ; 2018 Oct; 363():k4029. PubMed ID: 30361202
[TBL] [Abstract][Full Text] [Related]
14. An immunopotentiator, ophiopogonin D, encapsulated in a nanoemulsion as a robust adjuvant to improve vaccine efficacy.
Tong YN; Yang LY; Yang Y; Song Z; Peng LS; Gao JN; Zeng H; Zou QM; Sun HW; Mao XH
Acta Biomater; 2018 Sep; 77():255-267. PubMed ID: 30031164
[TBL] [Abstract][Full Text] [Related]
15. Immunogenicity and Safety of an Adjuvanted Herpes Zoster Subunit Vaccine Coadministered With Seasonal Influenza Vaccine in Adults Aged 50 Years or Older.
Schwarz TF; Aggarwal N; Moeckesch B; Schenkenberger I; Claeys C; Douha M; Godeaux O; Grupping K; Heineman TC; Fauqued ML; Oostvogels L; Van den Steen P; Lal H
J Infect Dis; 2017 Dec; 216(11):1352-1361. PubMed ID: 29029224
[TBL] [Abstract][Full Text] [Related]
16. Retraction notice to "Corrigendum to "MLL1 promotes migration and invasion of fibroblast-like synoviocytes in rheumatoid arthritis by activating the TRIF/NF-κB signaling pathway via H3K4me3 enrichment in the TLR4 promoter region"" [Int. Immunopharmacol. 82 (2020) 106220] [Int. Immunopharmacol. 92 (2021) 107321].
Zhang Y; Ji T; Ma S; Wu W
Int Immunopharmacol; 2023 Apr; 117():109865. PubMed ID: 36822094
[No Abstract] [Full Text] [Related]
17. Safety and immunogenicity of an adjuvanted herpes zoster subunit candidate vaccine in HIV-infected adults: a phase 1/2a randomized, placebo-controlled study.
Berkowitz EM; Moyle G; Stellbrink HJ; Schürmann D; Kegg S; Stoll M; El Idrissi M; Oostvogels L; Heineman TC;
J Infect Dis; 2015 Apr; 211(8):1279-87. PubMed ID: 25371534
[TBL] [Abstract][Full Text] [Related]
18. Vaccines for preventing herpes zoster in older adults.
Gagliardi AM; Andriolo BN; Torloni MR; Soares BG; de Oliveira Gomes J; Andriolo RB; Canteiro Cruz E
Cochrane Database Syst Rev; 2019 Nov; 2019(11):. PubMed ID: 31696946
[TBL] [Abstract][Full Text] [Related]
19. Corrigendum to "(E)-2-methoxy-4-(3-(4-methoxyphenyl)prop-1-en-1-yl)phenol alleviates inflammatory responses in LPS-induced mice liver sepsis through inhibition of STAT3 phosphorylation" [Int. Immunopharmacol. 125(Part B) (2023) 111124].
Kim B; Yu JE; Yeo IJ; Son DJ; Lee HP; Roh YS; Lim KH; Yun J; Park H; Han SB; Hong JT
Int Immunopharmacol; 2024 Jun; ():112543. PubMed ID: 38926074
[No Abstract] [Full Text] [Related]
20. Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults.
Lal H; Cunningham AL; Godeaux O; Chlibek R; Diez-Domingo J; Hwang SJ; Levin MJ; McElhaney JE; Poder A; Puig-Barberà J; Vesikari T; Watanabe D; Weckx L; Zahaf T; Heineman TC;
N Engl J Med; 2015 May; 372(22):2087-96. PubMed ID: 25916341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]